These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 27202195)

  • 1. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.
    Lardinois D; Weder W; Hany TF; Kamel EM; Korom S; Seifert B; von Schulthess GK; Steinert HC
    N Engl J Med; 2003 Jun; 348(25):2500-7. PubMed ID: 12815135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The optimality of different strategies for supplemental staging of non-small-cell lung cancer: a health economic decision analysis.
    Søgaard R; Fischer BM; Mortensen J; Rasmussen TR; Lassen U
    Value Health; 2013; 16(1):57-65. PubMed ID: 23337216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can positron emission tomography be used as a staging tool for small-cell lung cancer?
    Vinjamuri M; Craig M; Campbell-Fontaine A; Almubarak M; Gupta N; Rogers JS
    Clin Lung Cancer; 2008 Jan; 9(1):30-4. PubMed ID: 18282355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A follow-up of integrated positron emission tomography/computed tomography after curative resection of non-small-cell lung cancer in asymptomatic patients.
    Cho S; Lee EB
    J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1447-51. PubMed ID: 20005529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediastinal staging of non-small cell lung carcinoma using computed and positron-emission tomography.
    Kiernan PD; Sheridan MJ; Lamberti J; Dicicco B; Wigton R; Hetrick V; Vaughan B; Graling P
    South Med J; 2002 Oct; 95(10):1168-72. PubMed ID: 12425503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
    Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is palpation of the nonresected pulmonary lobe(s) required for patients with non-small cell lung cancer? A prospective study.
    Cerfolio RJ; Bryant AS
    J Thorac Cardiovasc Surg; 2008 Feb; 135(2):261-8. PubMed ID: 18242247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advantages of positron emission tomography over computed tomography in mediastinal staging of non-small cell lung cancer.
    von Haag DW; Follette DM; Roberts PF; Shelton D; Segel LD; Taylor TM
    J Surg Res; 2002 Apr; 103(2):160-4. PubMed ID: 11922730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18 F-fluorodeoxyglucose positron emission tomography-computed tomography for preoperative lymph node staging in patients undergoing radical cystectomy for bladder cancer: a prospective study.
    Hitier-Berthault M; Ansquer C; Branchereau J; Renaudin K; Bodere F; Bouchot O; Rigaud J
    Int J Urol; 2013 Aug; 20(8):788-96. PubMed ID: 23279605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT and PET imaging in non-small cell lung cancer.
    Knoepp UW; Ravenel JG
    Crit Rev Oncol Hematol; 2006 Apr; 58(1):15-30. PubMed ID: 16386435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron Emission Tomography/Computed Tomography Imaging for Non-Small Cell Lung Cancer: A Budget Impact Analysis.
    Wichmann RM; Freitas MG; Silva MT
    Value Health; 2014 Nov; 17(7):A623. PubMed ID: 27202195
    [No Abstract]   [Full Text] [Related]  

  • 12. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results.
    Nomori H; Mori T; Ikeda K; Kawanaka K; Shiraishi S; Katahira K; Yamashita Y
    J Thorac Cardiovasc Surg; 2008 Apr; 135(4):816-22. PubMed ID: 18374761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer.
    Meyers BF; Haddad F; Siegel BA; Zoole JB; Battafarano RJ; Veeramachaneni N; Cooper JD; Patterson GA
    J Thorac Cardiovasc Surg; 2006 Apr; 131(4):822-9; discussion 822-9. PubMed ID: 16580440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative mediastinal and hilar nodal staging with diffusion-weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer: which is better?
    Wu LM; Xu JR; Gu HY; Hua J; Chen J; Zhang W; Haacke EM; Hu J
    J Surg Res; 2012 Nov; 178(1):304-14. PubMed ID: 22541065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT, positron emission tomography, and MRI in staging lung cancer.
    Erasmus JJ; Sabloff BS
    Clin Chest Med; 2008 Mar; 29(1):39-57, v. PubMed ID: 18267183
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.